• Fingerstick Capillary Blood Test
• As Easy to Use as Self-Testing for Blood Glucose
• Allows Screening or Monitoring of Kidney Disease
• Based on Nova’s Proven Hospital Creatinine/eGFR Meter
Nova Max Creatinine/eGFR is an important new tool to improve kidney care through detection of kidney disease early enough to successfully treat the disease. Nova Max is a fast, accurate and easy to use meter and biosensor for kidney function testing. The measurement technique is very easy to use, virtually identical to the use of a glucose meter by people with diabetes. Creatinine and estimated glomerular filtration rate (eGFR) results are reported (with or without race as a factor) using the CKD-EPI equation from a small, capillary fingerstick blood sample in just 30 seconds. Test results can be wirelessly communicated to Bluetooth enabled applications for review and intervention by healthcare professionals.
Accuracy
Nova’s FDA cleared StatSensor Creatinine enzymatic technology has been used in hospital point-of-care meters for over 15 years. In a 2021 university medical center study of 670 patients sponsored by the International Society of Nephrology, Nova’s sensor technology proved more accurate than the laboratory Jaffe Creatinine/eGFR method when both methods were compared to the gold standard measured GFR (mGFR)
Very Good Correlation to Hospital Lab Analyzer
In a study performed for regulatory submission, 517 patients at three different sites had Nova Max Creatinine eGFR tests performed on fingerstick capillary blood samples. At the same time a venous blood sample was drawn and a laboratory analysis of creatinine/eGFR was performed.